U.S. Markets closed

Qualigen Therapeutics, Inc. (QLGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5600-0.1700 (-3.59%)
At close: 4:00PM EDT

4.6300 +0.07 (1.54%)
After hours: 7:59PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.7300
Bid4.5900 x 2200
Ask4.5900 x 1000
Day's Range4.5600 - 4.7500
52 Week Range3.7100 - 21.5000
Avg. Volume1,772,459
Market Cap102.736M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks Small Cap Research

    QLGN: Initiating Coverage of Qualigen Therapeutics, Inc.; Targeting Cancer and Infectious Diseases…

    By David Bautz, PhD NASDAQ:QLGN READ THE FULL QLGN RESEARCH REPORT We are initiating coverage of Qualigen Therapeutics, Inc. (NASDAQ:QLGN) with a valuation of $10.00. Qualigen is a biopharmaceutical company developing novel treatments for cancer and infectious diseases while continuing and expanding its FDA approved FastPack® System. The company’s development pipeline includes ALAN, featuring a